Company intelligence / Profile preview

Senecio Robotics

Kfar Saba, Israel

Ownership: Private
Employees: ~25
Development stage: Other

Overview

Senecio Robotics operates commercial deployments of its AI-driven Sterile Insect Technique platform for mosquito population suppression, reporting rapid population reductions (around 80% within weeks) and commercial service roll‑outs with municipal, residential and corporate customers, including a global agreement with Rentokil for large‑scale use.[5][6]

Therapeutic areas: Infectious Diseases
Modalities: DeviceNon-pharmacological therapy
Industry: Non-Drug Biotech

Partnerships

Rentokil Initial (commercial agreement for global mosquito control services)[5][6]Israel Innovation Authority (grant support)[1]BIRD Foundation (US–Israel bi-national program support)[1]European Union Horizon 2020 / European Commission (grant and EIC support)[1][5][6][12]

Beyond the preview

Go deeper on Senecio Robotics.

Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.

Clinical trials

Follow clinical development from trial design and recruitment through results.

Trial phase
Status
Readouts

Licensing & deals

Explore licensing agreements, acquisitions, and the assets behind each deal.

Partners
Deal terms
Milestones

Funding history

Trace financing activity and the investors behind a company’s development.

Funding rounds
Investors
Capital raised

Competitive landscape

Compare peer pipelines by target, modality, and therapeutic area.

Peer companies
Targets
Pipeline overlap

Technologies & patents

Explore technology platforms and the patent landscape around relevant assets.

Platforms
Patents
Assignees

Research & analysis

Connect company news and source material to the questions you’re investigating.

Company news
Sources
Analysis

Bring the full picture into focus.

See how Gosset can support your research on Senecio Robotics.

Explore the full profile